Item List

Feb 6, 2025

Startup Health

Polaris Genomics’ Platform Is Modernizing Mental Health with Molecular Biomarkers

The company’s successful identification of biomarkers for post-traumatic stress disorder (PTSD) has evolved into mapping molecular biomarkers for a wide range of mental health diagnostics and novel therapeutics.

Recent Posts

Portfolio Company

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinica ...

Businesswire

Apr 30, 2026

Portfolio Company

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectr ...

BioSpace

Apr 16, 2026

Portfolio Company

The most innovative healthcare companies of 2026 ...

Fast Company

Mar 24, 2026